Scios Safety Study of Natrecor
Scios Safety Study of Natrecor. Scios Inc. announced on Thursday that it would spend more than $100 million to conduct a safety and effectiveness study of its controversial heart failure drug, Natrecor. The trial is designed to address safety issues swirling around the drug since last year when other studies suggested … [Read more...] about Scios Safety Study of Natrecor
Scios Heart Drug Curbed
Scios Heart Drug Natrecor Not Approved By FDA. Fremont biotechnology firm Scios Inc. is taking the first of a series of steps to curb prescribing of its heart drug Natrecor for uses not approved by the Food and Drug Administration. The company, a unit of Johnson & Johnson, had been accused of promoting those unapproved uses by … [Read more...] about Scios Heart Drug Curbed
